Clariant 배당 및 자사주 매입
배당 기준 점검 4/6
Clariant 은(는) 현재 수익률이 3.86% 인 배당금 지급 회사입니다.
핵심 정보
3.9%
배당 수익률
0.1%
자사주 매입 수익률
| 총 주주 수익률 | 4.0% |
| 미래 배당 수익률 | 4.4% |
| 배당 성장률 | -1.3% |
| 다음 배당 지급일 | n/a |
| 배당락일 | n/a |
| 주당 배당금 | n/a |
| 배당 성향 | -444% |
최근 배당 및 자사주 매입 업데이트
Recent updates
CLN: Ongoing Ethylene Litigation Risk Will Limit Future Share Price Upside
Clariant's updated analyst price target has moved higher to CHF 7.00, with analysts largely pointing to improved earnings expectations into 2027 and reduced litigation risk following recent court outcomes as key drivers for the revised view. Analyst Commentary Recent research coverage on Clariant shows a clear tilt toward more constructive views, with several major banks lifting ratings and price targets.Clariant AG Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Shareholders will be ecstatic, with their stake up 28% over the past week following Clariant AG 's ( VTX:CLN ) latest...CLN: Lower Litigation Risk And Specialty Focus Will Drive Re Rating Potential
Clariant's updated analyst price target now stands at CHF 12.56 versus CHF 10.97 previously, with analysts pointing to a series of recent upgrades, lower perceived litigation risk, and adjustments to revenue growth, profit margin, and future P/E assumptions as key drivers of the change. Analyst Commentary Recent research on Clariant shows a clear split between cautious and bullish analysts, with the upside camp focusing on litigation risk, valuation support, and the company’s positioning within European chemicals.CLN: Pricing Power And Specialty Focus Will Drive Re Rating Potential
Clariant's analyst price target has been revised lower by CHF 1.40 to reflect a recalibrated fair value, with analysts citing recent cuts to CHF 7.50 from Deutsche Bank and Citi, as well as more balanced views from Goldman Sachs at CHF 8.50 and JPMorgan at CHF 9.30, as they reassess the stock's quality profile, pricing power and valuation. Analyst Commentary Recent research on Clariant points to a mixed but increasingly constructive tone, with several bullish analysts highlighting improving quality perceptions and a more supportive view on valuation.CLN: Weaker Revenue Outlook And Conflict Exposure Will Restrain Future Upside
Analysts have modestly raised their fair value estimate for Clariant to CHF 6.00. Recent Street research, including a reduced price target of CHF 7.50 at Citi and an upgrade to Overweight with a CHF 9.30 target at JPMorgan, highlights differing views that center on discounted valuation and expectations for a higher-quality specialty chemicals profile.CLN: Overweight Upgrade And Specialty Focus Will Shape Measured Forward Expectations
Analysts have trimmed their fair value estimate for Clariant to about CHF 8.58 from CHF 8.84, while still pointing to a CHF 9.30 price target. This target is supported by views that the stock’s current discounted valuation offers exposure to a higher quality specialty chemicals profile.CLN: Trimmed Assumptions And Downgrades Will Shape Measured Forward Expectations
Analysts have trimmed their price target on Clariant by CHF 0.09 to reflect updated assumptions on fair value, discount rate, revenue growth, profit margin and future P/E, in line with recent research that includes a downgrade from some firms. Analyst Commentary Bullish Takeaways Bullish analysts see the revised fair value and discount rate assumptions as more realistic.CLN: Earnings Quality And Steadier Cash Generation Will Support Bullish Re Rating
Analysts have trimmed their price target on Clariant to CHF 12.37 from CHF 12.77, citing updated assumptions on discount rates, revenue growth, profit margins and future P/E following recent research, including a downgrade from Goldman Sachs. Analyst Commentary While the latest research includes a downgrade from Goldman Sachs, some views across the Street remain constructive, focusing on how Clariant could still convert its fundamentals into long term value creation.CLN: Recent Downgrade And Trimmed Assumptions Will Shape Potential Upside
Analysts have trimmed their CHF price targets for Clariant by a small amount, reflecting more cautious assumptions on revenue growth and profit margins. They are still applying a slightly higher future P/E multiple in their updated models.CLN: Lower CHF 7.80 Outlook Will Restrain Upside As Legal Claims Persist
Analysts have trimmed their average price target on Clariant to CHF 7.80 from CHF 8.00, reflecting slightly softer expectations that align with recent downgrades and more cautious assumptions on growth and returns. Analyst Commentary Recent research points to a more cautious stance on Clariant, with the latest moves reflecting concerns around execution, growth visibility and how the current share price lines up with those risks.CLN: Legal Claims And Recent Downgrade Will Frame Potential Upside Ahead
Analysts have trimmed their price expectations for Clariant, with the average target moving modestly lower to around CHF 7.80. This reflects updated assumptions on fair value, discount rates and future P/E in light of recent research calls.CLN: Legal Claims And Rating Downgrade Will Shape Measured Future Upside Potential
The updated analyst price target for Clariant now stands at CHF 8.80, a small change from the prior CHF 8.74, as analysts factor in recent target cuts around CHF 7.80 and adjust their assumptions on discount rates, revenue growth, profit margins, and future P/E multiples. Analyst Commentary Bullish Takeaways Bullish analysts see the updated CHF 8.80 target as reflecting a more refined view of discount rates and earnings power, rather than a fundamental shift in the story.CLN: Lower CHF 7.80 Outlook Will Cap Upside As Legal Claims Linger
Analysts have reduced their price target on Clariant to CHF 7.80 from CHF 8.00 to reflect updated views on the company’s discount rate, revenue growth assumptions, profit margins and future P/E. Analyst Commentary Bearish analysts are signaling a more cautious stance on Clariant by aligning their valuation work with a CHF 7.80 price level.CLN: Revised Expectations And Legal Claims Will Shape Future Upside Potential
Analysts have reduced their price target for Clariant to CHF 7.80 from CHF 8.00, citing updated assumptions for fair value, discount rate, revenue growth, profit margins, and future P/E multiples. Analyst Commentary Recent research points to a more cautious stance on Clariant, with the price target trimmed to CHF 7.80 from CHF 8 and the rating held steady at Hold.CLN: Legal Claims And Steady Earnings Outlook Will Support Bullish Re Rating
Analysts have trimmed their price target on Clariant to CHF 7.80, reflecting updated assumptions for fair value, revenue growth, margins and future P/E multiples following recent research. Analyst Commentary Recent research points to a more measured stance on Clariant, with the revised CHF 7.80 target reflecting updated views on valuation, earnings power and the multiples investors might be willing to pay for the shares.CLN: Reduced Price Outlook Will Limit Upside Amid Rising Legal Risks
Analysts have reduced their price target on Clariant by CHF 1.50 to CHF 8.10, reflecting more cautious assumptions on revenue growth and valuation multiples, even though margin expectations have improved slightly. Analyst Commentary Bearish analysts have framed the lower price target as a reflection of rising skepticism around Clariant's ability to deliver on its medium term growth ambitions, despite recent progress on margins.CLN: Margin Recovery And Legal Overhang Will Shape Future Share Resilience
Analysts have trimmed their price target on Clariant by CHF 1.50 to reflect a slightly lower assumed future price to earnings multiple and discount rate, even as forecasts for profit margins have improved. Analyst Commentary Analysts remain balanced in their view on Clariant, with modest adjustments to valuation assumptions reflecting both improving profitability and lingering execution risks.CLN: Market Recovery And Margin Discipline Will Drive Future Share Resilience
Clariant's analyst price target has been revised downward from CHF 9.78 to CHF 9.51. Analysts cite tempered expectations for near-term performance amid evolving market conditions.CLN: Margin Improvements And Efficiency Efforts Will Offset Market Headwinds
Analysts have reduced their price target for Clariant from CHF 9.60 to CHF 8.10. This adjustment reflects lowered growth expectations and a more cautious outlook on the company's future performance.Cautious Investors Not Rewarding Clariant AG's (VTX:CLN) Performance Completely
There wouldn't be many who think Clariant AG's ( VTX:CLN ) price-to-earnings (or "P/E") ratio of 20.4x is worth a...Earnings Recovery Will Depend On Stabilization And Cost Improvements Amid Headwinds
Narrative Update: Clariant Analyst Price Target Adjustment Clariant’s analyst price target has been reduced significantly, dropping from CHF 9.60 to CHF 8.10. Analysts cite softer revenue growth and profit margin expectations in their revised outlook.China Expansion And Sustainable Solutions Will Boost Long-Term Appeal
Narrative Update on Clariant Clariant's analyst price target has been revised downward from CHF 10.95 to CHF 10.58. Analysts cite a combination of cautious revenue growth assumptions and a recent reduction in price targets by major banks.China Expansion And Sustainable Solutions Will Boost Long-Term Appeal
The minor decrease in Clariant's price target reflects a combination of lower revenue growth expectations and a modestly higher discount rate, resulting in a slight fair value reduction to CHF10.95. What's in the News Clariant AG dropped from the FTSE All-World Index (USD).Is Clariant AG (VTX:CLN) Trading At A 32% Discount?
Key Insights Clariant's estimated fair value is CHF11.89 based on 2 Stage Free Cash Flow to Equity Current share price...We Think Clariant (VTX:CLN) Is Taking Some Risk With Its Debt
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Clariant's (VTX:CLN) Anemic Earnings Might Be Worse Than You Think
SWX:CLN 1 Year Share Price vs Fair Value Explore Clariant's Fair Values from the Community and select yours Clariant...Clariant (VTX:CLN) Has Affirmed Its Dividend Of CHF0.42
Clariant AG ( VTX:CLN ) has announced that it will pay a dividend of CHF0.42 per share on the 4th of June. Based on...These 4 Measures Indicate That Clariant (VTX:CLN) Is Using Debt Extensively
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Are Investors Undervaluing Clariant AG (VTX:CLN) By 39%?
Key Insights Using the 2 Stage Free Cash Flow to Equity, Clariant fair value estimate is CHF13.37 Current share price...Clariant AG's (VTX:CLN) CEO Might Not Expect Shareholders To Be So Generous This Year
Key Insights Clariant's Annual General Meeting to take place on 1st of April Salary of CHF1.20m is part of CEO Conrad...Clariant AG Just Missed EPS By 6.0%: Here's What Analysts Think Will Happen Next
It's been a sad week for Clariant AG ( VTX:CLN ), who've watched their investment drop 10% to CHF9.76 in the week since...Take Care Before Diving Into The Deep End On Clariant AG (VTX:CLN)
When close to half the companies in Switzerland have price-to-earnings ratios (or "P/E's") above 21x, you may consider...Restructuring, Lucas Meyer Cosmetics, And Sunliquid Set To Boost Margins And Drive Earnings
Identifying restructuring opportunities and targeting significant savings could improve Clariant's net margins and earnings efficiency in the coming years.Estimating The Intrinsic Value Of Clariant AG (VTX:CLN)
Key Insights The projected fair value for Clariant is CHF10.85 based on 2 Stage Free Cash Flow to Equity Clariant's...It's A Story Of Risk Vs Reward With Clariant AG (VTX:CLN)
Clariant AG's ( VTX:CLN ) price-to-sales (or "P/S") ratio of 0.9x might make it look like a strong buy right now...Clariant's (VTX:CLN) Solid Earnings Have Been Accounted For Conservatively
The stock was sluggish on the back of Clariant AG's ( VTX:CLN ) recent earnings report. Our analysis suggests that...Why Investors Shouldn't Be Surprised By Clariant AG's (VTX:CLN) Low P/S
Clariant AG's ( VTX:CLN ) price-to-sales (or "P/S") ratio of 1.1x might make it look like a strong buy right now...What Is Clariant AG's (VTX:CLN) Share Price Doing?
Clariant AG ( VTX:CLN ), might not be a large cap stock, but it received a lot of attention from a substantial price...지급의 안정성과 성장
배당 데이터 가져오는 중
안정적인 배당: CLN 의 배당금 지급은 지난 10 년 동안 휘발성이었습니다.
배당금 증가: CLN 의 배당금 지급은 지난 10 년 동안 증가했습니다.
배당 수익률 vs 시장
| Clariant 배당 수익률 vs 시장 |
|---|
| 구분 | 배당 수익률 |
|---|---|
| 회사 (CLN) | 3.9% |
| 시장 하위 25% (CH) | 2.0% |
| 시장 상위 25% (CH) | 3.6% |
| 업계 평균 (Chemicals) | 3.1% |
| 분석가 예측 (CLN) (최대 3년) | 4.4% |
주목할만한 배당금: CLN 의 배당금( 3.86% )은 Swiss 시장에서 배당금 지급자의 하위 25%( 1.96% )보다 높습니다.
고배당: CLN 의 배당금( 3.86% )은 Swiss 시장( 3.65% )
주주 대상 이익 배당
수익 보장: CLN 배당금을 지급하고 있지만 회사는 수익성이 없습니다.
주주 현금 배당
현금 흐름 범위: 합리적으로 낮은 현금 지급 비율 ( 40.4% )로 CLN 의 배당금 지급은 현금 흐름으로 잘 충당됩니다.
높은 배당을 제공하는 우량 기업 찾기
기업 분석 및 재무 데이터 상태
| 데이터 | 최종 업데이트 (UTC 시간) |
|---|---|
| 기업 분석 | 2026/08/19 01:39 |
| 종가 | 2026/08/19 00:00 |
| 수익 | 2026/06/30 |
| 연간 수익 | 2025/12/31 |
데이터 소스
당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.
| 패키지 | 데이터 | 기간 | 미국 소스 예시 * |
|---|---|---|---|
| 기업 재무제표 | 10년 |
| |
| 분석가 컨센서스 추정치 | +3년 |
|
|
| 시장 가격 | 30년 |
| |
| 지분 구조 | 10년 |
| |
| 경영진 | 10년 |
| |
| 주요 개발 | 10년 |
|
* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.
별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.
분석 모델 및 스노우플레이크
이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.
Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.
산업 및 섹터 지표
산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.
분석가 소스
Clariant AG는 34명의 분석가가 다루고 있습니다. 이 중 15명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
| 분석가 | 기관 |
|---|---|
| Volker Bosse | Baader Helvea Equity Research |
| Konstantin Wiechert | Baader Helvea Equity Research |
| James Stewart | Barclays |